Transplants, Degiorgi (Takeda): “Maximizing successes with targeted therapies”

(Adnkronos) – On the occasion of the press conference ‘Donation is wealth not to be wasted. Cytomegalovirus (cmv) infection, a threat after transplantation’, Andrea Degiorgi, Rare Business Unit Head of Takeda Italia spoke.